Related Experiment Video
Updated: Feb 3, 2026

Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors
Published on: April 13, 2019
Infants Are Exposed to Human Milk Oligosaccharides Already in utero
Audra Wise1,2, Bianca Robertson1,2, Biswa Choudhury3
1Department of Pediatrics, University of California, San Diego, La Jolla, CA, United States.
Insights
Human milk oligosaccharides (HMOs) are present in amniotic fluid, exposing the fetus during pregnancy. This finding suggests potential impacts on fetal and infant development, requiring further investigation.
Area of Science:
- Biochemistry
- Human Lactation
- Perinatal Medicine
Background:
- Human milk oligosaccharides (HMOs) are unique, complex carbohydrates found in human milk.
- Postnatal exposure to HMOs influences infant health and development.
- Previous studies indicated HMO presence in maternal blood and urine during pregnancy.
Purpose of the Study:
- To investigate the presence of HMOs in amniotic fluid.
- To determine if fetuses are exposed to HMOs in utero.
Main Methods:
- Pilot study involving pregnant women.
- Collection of maternal urine, amniotic fluid, and milk samples.
- Analysis using high-performance liquid chromatography (HPLC) and mass spectrometry.
Main Results:
- Identified several HMOs (e.g., 2'-fucosyllactose, 6'-sialyllactose) in amniotic fluid, urine, and milk.
- This is the first report of HMOs in amniotic fluid.
- Demonstrated fetal exposure to HMOs in utero.
Conclusions:
- HMOs are present in amniotic fluid, indicating in utero fetal exposure.
- Further research is needed to understand the implications for fetal and infant health.
- This discovery opens new avenues for studying early-life nutrition and development.
Abstract:
Human milk oligosaccharides (HMOs) are complex carbohydrates that are highly abundant in and, in their complexity, unique to human milk. Accumulating evidence indicates that exposure to HMOs in the postnatal period affects immediate as well as long-term infant health and development. However, studies reported in the 1970s showed that HMOs already appear in maternal urine and blood during pregnancy and as early as the first trimester. In this pilot study we aimed to determine whether or not HMOs also appear in amniotic fluid. We enrolled women during pregnancy and collected their urine and amniotic fluid at birth as well as their milk 4 days postpartum. We analyzed the samples by high-performance liquid chromatography (HPLC) and mass spectrometry and identified several HMOs including 2'-fucosyllactose, 3-fucosyllactose, difucosyllactose, and 6'-sialyllactose to be present in different relative abundancies in all three tissues. This is the first report that HMOs appear in amniotic fluid and that the fetus is already exposed to HMOs in utero, warranting future research to investigate the immediate and long-term implications on fetal and infant health and development.
Related Concept Videos
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Drug Dosing: Infants and Children
Design Example: Calculating Safe Diameter for Wind-Exposed Disc
Biodiversity and Human Values
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...

